TAMIKI MEHAFFEY: Open Payments
NPI 1578107132 · BURGETTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 31 payments from 11 companies in 2025. Trend: 2023 $1,106 · 2024 $1,401 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| Amgen Inc. | 4 | $73 |
| Viatris Specialty LLC | 4 | $65 |
| Exact Sciences Corporation | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Corcept Therapeutics | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Wegovy, REPATHA, YUPELRI, Kerendia, BRILINTA, FARXIGA, Cologuard Collection Kit, LEQVIO.
Industry payments across PA — which companies pay providers there.
